Rhabdomyosarcoma clinical trial development… at the speed of biotech?

We are excited to announce the establishment of the Children's Cancer Therapy Development Institute, (cc-TDI) a research laboratory in the model of a non-profit biotech. Our goal? To take the best science of rhabdomyosarcoma and other pediatric cancers, validate it in preclinical (mouse) models, and speed the initiation of well-founded clinical trials in partnership with pharma and cooperative groups. We have 4 such projects already in the pipeline, 2 of which are progressing to clinical trial design. Come be a part of this effort of Scientists and Families partnering for cancer cures!

obligate disclaimer: Alan and Charles (co-founders of FocusOnRhabdo) are also the leadership team of cc-TDI.

Upcoming Webinars

Featured Posts

There is an important kind of rhabdo clinical trial that is presently hindered by lack of bio-specimens. Specifically, the trials focus on creating individualized therapies for relapsed rhabdo patients. In ... Read More